Back to Resources

Right to Win Memo: Preempt Investor Doubts

RaiseSimpli Team
10/23/2026
15 min read
Right to Win Memo: Preempt Investor Doubts

How a Right to Win memo helps you address investor doubts early and control the fundraising narrative in ways a pitch deck alone cannot.

Why a “Right to Win” memo exists (and why decks don’t solve this)

Most fundraising advice focuses on the pitch deck: tell a crisp story, show traction, demonstrate market size, and articulate the product. That’s necessary, but it’s not sufficient.

Investors don’t only ask “Is this interesting?” They ask, often implicitly:

  • Is this market real, now, at venture scale?

  • Is the moat durable or just a feature?

  • Can this team actually get distribution, or will CAC blow up?
  • A deck is optimized for excitement and recall. It is not optimized for skepticism management. In fact, decks often make skepticism worse by:

  • compressing nuance into slogans (which invites “hand-wavy” reactions),

  • emphasizing upside while leaving obvious holes unaddressed,

  • relying on “trust us” statements about competition, defensibility, and GTM.
  • The result is predictable: after a good meeting, the investor goes to their internal decision process (partner meeting / IC / memo-writing), and the doubts that weren’t pre-empted become the reasons to pass.

    A one-page “Right to Win” memo is designed to interrupt that dynamic. It is a deliberately structured, high-signal document that answers the hardest questions before they’re asked, so the investor’s internal narrative becomes:

    > “They’ve seen the risks clearly, they have a plan, and they’re already executing against it.”

    If you do this well, two things happen:

  • Conviction rises because uncertainty drops.

  • Diligence shortens because the investor knows exactly what to verify.
  • This is not a replacement for a deck or data room. It’s the missing bridge between “compelling story” and “investable belief.”


    What investors are actually doing: reducing downside narratives

    Venture investing is often described as upside hunting. Operationally, though, early-stage decision-making is frequently about eliminating downside narratives that could embarrass the firm or fail IC.

    Typical internal objections sound like:

  • “The market isn’t ready; this is a science project.”

  • “Google/Stripe/OpenAI will launch this in six months.”

  • “It’s a nice product, but distribution will be brutal.”

  • “They have some pilots, but no repeatable sales motion.”

  • “Margins will compress; there’s no pricing power.”
  • Your goal is not to “argue” investors out of skepticism. Your goal is to make the skeptical story less plausible than your story: using clear reasoning, specific evidence, and explicit tradeoffs.

    A good Right to Win memo does three things:

  • Names the skepticism in plain language (showing awareness).

  • Frames why the skepticism is incomplete (showing strategic clarity).

  • Anchors on verifiable proofs and near-term milestones (showing execution).

  • The one-page constraint is the feature, not the bug

    One page forces discipline:

  • You can’t hide behind jargon.

  • You must choose the few decisive points.

  • You must clarify what matters now versus what will be true later.
  • This matches how partners actually operate. In many firms, an internal champion has to summarize the deal in a few minutes (sometimes less). If you give them a tight one-pager that already handles the major objections, you are effectively writing the first draft of the partner narrative.

    This is similar in spirit to Amazon’s famous memo culture (narratives over slides) where structured writing reveals gaps in thinking and improves decision quality ([Amazon writing culture overview](https://www.inc.com/justin-bariso/jeff-bezos-amazon-6-page-memo-writing.html)). You don’t need a six-page memo for fundraising, but you do need the same rigor.


    When to use it in a fundraising process

    Use the Right to Win memo when you have:

  • a market that appears “crowded” or “hyped,”

  • a product that could be dismissed as “a feature,”

  • a GTM motion that is non-obvious (enterprise, platform shift, regulated industry, devtools wedge, etc.),

  • a technical insight that’s hard to explain in a deck,

  • early traction that is promising but not yet decisive.
  • Practical timing:

  • Send after the first meeting as a follow-up: “Here’s how we think about why we’ll win, and the risks we’re actively de-risking.”

  • Send before partner meeting once someone is leaning in.

  • Include as a data room artifact so diligence stays pointed.
  • Do not send it as a cold outbound attachment. Cold outreach needs fast curiosity; the memo is for converting curiosity into commitment.


    The Right to Win memo: a practical one-page framework

    Below is a structure that fits on one page if written tightly (roughly 600–900 words).

    1) One-sentence claim: “We have a right to win because…”

    This is not a slogan. It should be falsifiable.

    Template:

    > “We have a right to win in [market] because [unique capability / wedge] gives us [distribution or product advantage] that compounds into [durable position].”

    Example (illustrative):

    > “We have a right to win in SMB financial automation because our embedded workflow + bank data graph turns reconciliation into a default behavior inside existing tools, creating switching costs and a data advantage that improve accuracy and reduce fraud over time.”

    This sets a clear thesis: wedge → compounding advantage → defensibility.


    2) The top 3 investor doubts (stated bluntly)

    Name the doubts the way a skeptical partner would.

    Example section header:

    > “The skeptical view (and why it’s reasonable):”

    Then list three bullets, typically aligned to:

  • Market skepticism (timing, TAM, budget owner, willingness to pay)

  • Moat skepticism (copyability, incumbents, open source, platform risk)

  • GTM skepticism (distribution, CAC, sales cycle, churn, implementation)
  • Be fair. If you strawman, you lose credibility.


    3) Rebuttal by proof, not by assertion

    For each doubt, provide:

  • Why the doubt is incomplete (logic)

  • What evidence you have now (proof)

  • What will be true in 6–12 months if you’re right (milestones)
  • A tight format looks like:

    Doubt → What’s true → Proof → Next verification

    #### A) Market skepticism

    Common investor questions:

  • Is the market big enough, at your price point?

  • Is budget allocated or “innovation theater”?

  • Is this a new category with long adoption cycles?
  • What good looks like in the memo:

  • Identify who pays (economic buyer) and why now.

  • Tie willingness-to-pay to a measurable KPI (revenue, cost, risk reduction).

  • Show you understand substitutes (status quo, manual process, incumbent).
  • Evidence investors respect:

  • Pipeline quality metrics (not just “LOIs”): stage conversion, cycle time, win/loss reasons.

  • Usage intensity that maps to value (frequency, time-to-value, retention cohorts).

  • Budget line items (where it comes from) and procurement path.
  • References to ground your framing:

  • Frameworks like crossing the chasm (category adoption) are useful shorthand, though not a substitute for data ([Geoffrey Moore](https://en.wikipedia.org/wiki/Crossing_the_Chasm)).

  • Market sizing is notoriously easy to inflate; serious investors often prefer bottom-up logic tied to distribution constraints over top-down TAM slides ([Bessemer’s sizing guidance](https://www.bvp.com/atlas) is a good compendium of thinking across growth and early-stage).
  • #### B) Moat fragility

    Investors often say “moat” but mean “why won’t this be competed away?”

    In software, defensibility tends to come from compounding advantages, not static features. The memo should make compounding explicit.

    Common defensibility vectors:

  • Data advantage (only if it is proprietary, improving the product, and hard to replicate)

  • Workflow lock-in / switching costs (embedded in daily operations)

  • Distribution advantage (ecosystem, community, channel partnerships)

  • Technical advantage (hard-to-build systems, latency, reliability, security)

  • Regulatory advantage (certifications, approvals, compliance processes)

  • Economies of scale (unit costs drop with volume; pricing power improves)
  • A useful mental model is to describe the flywheel: action → data/learning → product improvement → more adoption.

    Be careful with weak moat claims:

  • “We use AI” is not a moat.

  • “First mover” is rarely a moat.

  • “Our model is better” is a temporary advantage unless tied to proprietary data, distribution, or sustained iteration loops.
  • This aligns with broader commentary that ML/AI advantage often decays without data/network effects and iteration velocity (see analysis in industry writing like Benedict Evans’ essays on platforms and aggregation dynamics: https://www.ben-evans.com/).

    #### C) Go-to-market risk

    GTM is where most early-stage companies die, not because the product is bad, but because distribution is misunderstood.

    The memo should answer:

  • Who is the initial ICP and why them?

  • What is the wedge use case (the “beachhead”)?

  • How do you reach them repeatedly (channel)?

  • What is the sales motion (PLG, sales-led, hybrid) and why?

  • What breaks as you scale (support, onboarding, compliance, pricing)?
  • Avoid generic claims like “We’ll do content marketing” or “We’ll hire AEs.” Instead, specify a repeatable engine.

    Examples of credible GTM de-risking proofs:

  • A short payback period in pilots (or a clear path to one).

  • Clear activation metric correlated with retention.

  • Implementation time trending down.

  • References that show expansion potential.
  • Good GTM memos often mirror the discipline in modern startup metrics thinking (activation, retention cohorts, net revenue retention for B2B) as popularized in open resources like a16z’s operational content (https://a16z.com/).


    4) The “earned secrets” section (the most underused)

    Add 2–3 bullets titled something like:

    > “What we know that isn’t obvious from the outside:”

    This is where you include the specific insight you earned by building or selling:

  • “The real buyer is not the CTO; it’s the ops leader with an audit deadline.”

  • “The integration is the product; customers don’t care about the model.”

  • “The incumbent can’t ship this because it breaks their pricing model.”
  • This section is powerful because it signals non-consensus understanding, which is what VCs are paid to find.


    5) The milestones that convert belief into certainty

    End with 3–5 milestones over 90–180 days that, if hit, should make the round obvious.

    These should be:

  • measurable (numbers, dates, outcomes)

  • decision-relevant (reduce the biggest doubt)

  • credible (not “10x revenue” unless already trending there)
  • Examples:

  • “Reduce onboarding from 21 days to 5 days; maintain >70% week-4 activation.”

  • “Close 6 paid design partners at $X ACV with legal/procurement completed.”

  • “Prove expansion: 30% of customers add second workspace within 60 days.”
  • This gives investors a diligence map and tells them what “progress” means.


    A complete one-page template (copy/paste)

    Use this structure and keep it tight.

    ---

    Right to Win Memo

    Core claim (1 sentence):

    The skeptical view (3 bullets):

    1) Market skepticism:

  • Why this skepticism is reasonable:

  • Why it’s incomplete:

  • Proof today (data points):

  • What we’ll prove next (90–180 days):
  • 2) Moat skepticism:

  • Why this skepticism is reasonable:

  • Why it’s incomplete:

  • Proof today (data points):

  • What we’ll prove next (90–180 days):
  • 3) GTM skepticism:

  • Why this skepticism is reasonable:

  • Why it’s incomplete:

  • Proof today (data points):

  • What we’ll prove next (90–180 days):
  • What we know that isn’t obvious (earned secrets):



  • Milestones that would make this inevitable (next 90–180 days):



  • ---


    How to write it so it actually works

    Write like a partner, not like marketing

    A Right to Win memo is not brand copy. It should feel like a clear internal document.

    Tactics:

  • Use plain language.

  • Prefer numbers over adjectives.

  • Admit real constraints (“Sales cycles are 90–120 days today; we’re reducing via…”), credibility compounds.
  • Don’t “win” every point; choose your tradeoffs

    Investors are suspicious of perfection. If you claim:

  • massive market,

  • zero competition,

  • instant virality,

  • strong moat,

  • low burn,

  • and fast enterprise sales,
  • …you sound inexperienced or dishonest.

    Instead, be explicit:

  • “We accept longer sales cycles because ACV and retention are structurally high.”

  • “We’re choosing a narrow ICP to nail repeatability before expanding.”
  • Tradeoffs are how strategy shows up on paper.

    Use “pre-mortems” to find the real doubts

    Before writing, run a pre-mortem: imagine the company failed in 24 months. Ask:

  • What were the 3 causes?

  • What did investors warn you about?

  • What did the market not care about?
  • Then turn those into the “skeptical view” bullets.

    This technique is well-supported in decision-making literature as a way to surface risks and reduce overconfidence (Gary Klein’s work on pre-mortems is widely cited; overview: https://en.wikipedia.org/wiki/Pre-mortem).


    The three big skepticism categories, deeper guidance and examples

    1) Market skepticism: timing beats size

    A common founder mistake is to respond to market skepticism with bigger TAM slides. But timing skepticism isn’t a sizing problem; it’s a willingness-to-pay now problem.

    Investors want to know:

  • Is there a forcing function (regulation, platform shift, budget change, labor scarcity)?

  • Is the pain acute or chronic?

  • Are buyers actively seeking solutions or passively curious?
  • Good memo move: highlight a forcing function.

    Examples of forcing functions:

  • Security/compliance changes

  • API deprecations / platform shifts

  • Cost pressure / headcount freezes (automation ROI)

  • New workflows driven by AI tooling
  • If you can connect your product to a forcing function, you shorten the “market education” fear.


    2) Moat skepticism: articulate the compounding loop

    Most “moat” discussions fail because they list assets, not dynamics.

    Instead of:

  • “We have integrations.”
  • Write:

  • “Integrations reduce time-to-value, which increases activation, which increases retained usage, which increases data coverage, which improves outcomes, which makes integrations more valuable.”
  • That is a defendable loop.

    Also address platform risk directly:

  • If you build on OpenAI, say what happens if prices rise or models commoditize.

  • If you build in an app ecosystem, explain what you do if the platform clones you.
  • Investors know platform dependency is real; acknowledging it and showing contingency planning is a credibility multiplier.

    Related reading on competitive strategy and “what is defensibility” can be anchored in classics like Porter’s competitive forces (overview: https://en.wikipedia.org/wiki/Porter%27s_five_forces) and modern platform analysis (Benedict Evans).


    3) GTM skepticism: show the motion, not the hope

    GTM is often where founders overgeneralize. “We’ll sell to enterprises” is not a plan.

    A strong memo specifies:

  • ICP definition: not “mid-market,” but “200–2000 employee healthcare providers with Epic integrations and compliance pain.”

  • Wedge use case: the one use case that gets fast adoption.

  • Distribution channel: outbound to a specific persona, partner channel, marketplace listing, community.

  • Sales/PLG mechanics: what triggers a sale, what expands, what renews.
  • Also include a statement about what makes CAC improve over time.

    If CAC does not improve, you need either:

  • pricing power (higher ACV / margins),

  • retention/expansion (NRR),

  • or a differentiated channel (partners/community).
  • This is why many investors look for evidence of retention and expansion even earlier than founders expect.


    Controlling the narrative without sounding defensive

    There’s a fine line: pre-empting doubts can sound defensive if you overdo it.

    Rules of thumb:

  • Only address the top three doubts. More than that signals fragility.

  • Use calm language: “This risk is real; here’s how we mitigate it.”

  • Tie each doubt to a verification plan (milestones), not an argument.
  • Your goal is to communicate: “We are not surprised by reality.”


    How this memo shortens diligence (mechanically)

    Investors do diligence to answer:

  • Is the market real?

  • Is the product needed and differentiated?

  • Will customers pay and stay?

  • Can this team execute?
  • A Right to Win memo speeds this up by:

  • telling the investor which references to call (“talk to these three design partners; ask them about time-to-value and switching costs”),

  • clarifying what data matters (activation, retention cohorts, conversion),

  • defining the testable claims (so diligence is verification, not exploration).
  • It also helps your champion internally: they can paste your points into their IC memo.


    Common failure modes (and how to avoid them)

    Failure mode 1: The memo is just a second deck

    If it reads like marketing copy, you lose the point. Make it analytical.

    Failure mode 2: Vague defensibility claims

    “Network effects” without specifying who the network is and what value increases with scale is worse than saying nothing.

    Failure mode 3: Confusing activity with proof

    “100 meetings” is activity. Proof is conversion, retention, paid willingness, and references who sound like they’d be upset if you disappeared.

    Failure mode 4: Overpromising milestones

    If you miss your own milestones, the memo becomes an artifact of unreliability. Choose milestones you can hit.


    Advanced move: write two versions (external + internal)

    If you have a strong lead investor or advisor, ask them for permission to write:

  • External one-pager (the version described here)

  • Internal “deal note” addendum (not broadly shared) with deeper detail: unit economics assumptions, pricing experiments, competitive teardown, and key diligence docs.
  • Some firms will effectively build this themselves; offering a structured version can accelerate the partnership.


    A final opinionated take: founders who name risks early raise faster

    Founders often worry that acknowledging risk will scare investors. In practice, sophisticated investors already see the risks; what they’re evaluating is whether you see them.

    The Right to Win memo is a signal of:

  • strategic clarity,

  • intellectual honesty,

  • operational focus,

  • and the ability to recruit believers.
  • It doesn’t replace traction. But it can:

  • convert “interesting” into “backable,”

  • turn a skeptical partner into a neutral one,

  • and give your internal champion the words they need.
  • If you can fit your right to win on one page, and make it read like it came from someone who has actually sold and built in the real world, you will control more of the narrative than the market will.

    RaiseSimpli Team

    Author

    View More Articles